Day-zero to day-30: the regulatory triage
The first 30 days are regulatory triage. Singapore cosmetics: HSA notification via PRISM, instant once submitted. Therapeutic products and health supplements with ingredients on the Register of Therapeutic Products: full registration, 3-6 months. Malaysia NPRA: classification first (FDI Committee, 2-4 weeks), then registration (drug 6-12 months, health supplement 3-6 months). Indonesia BPOM: cosmetics 2-3 months, supplements 4-6 months, plus October 2026 halal mandate adding 3-9 months on top. Thailand: notification 4-8 weeks for Class 1 devices on positive list; CSDT-required Class 2-3 several months. Philippines: LTO confirmation, then CPN 15-30 working days for cosmetics or CPR 20-60 working days for supplements. Vietnam: 3-4 weeks post-submission for health supplements with clean dossier.
For SSA: South Africa SAHPRA Cat D applications run through DL01-licensed importer with GMP/GDP confirmation. Botswana BoMRA, Namibia NMRC and Zimbabwe MCAZ run on ZAZIBONA collaborative procedure or country-level review — SAHPRA-registered products gain a meaningful priority path in BoMRA/NMRC reviews.
Day-30 to day-90: commercial scaffolding
Parallel to regulatory work, the commercial scaffolding takes 30-60 days. Distribution agreement negotiation: minimum order quantities, exclusivity (territory and category), termination clauses, marketing co-investment. Payment terms structure: letter of credit at sight is the brand's safest position but kills cash flow for distributors; net-60 to net-90 is the typical compromise; consignment for first 90-120 days is sometimes negotiable for new brand entries and accelerates time-to-shelf significantly.
COGS stress-test under 3-tier margin stacking is where most brand-distributor conversations break. A typical SEA premium clinic supply chain absorbs 40-50% gross margin at the distributor level and 50-60% gross margin at the clinic level. A brand wanting US$80 retail and US$30 brand revenue per unit needs the math to work: distributor buys at US$30, sells to clinic at US$50-55, clinic charges patient US$100-120. If the brand insists on US$45 brand revenue, the chain breaks — either retail moves to US$140 (above competitive band) or distributor margin compresses below 30% (no incentive).
Day-90 to day-120: first clinic order and post-launch
First clinic order typically lands 60-90 days after regulatory clearance, conditional on distributor sales rep capacity and clinic stock cycle. For a premium injectable brand entering Singapore: regulatory + commercial scaffolding 60-90 days, first 5-10 clinic onboardings 30-45 days, first revenue at day 90-120. For a halal-certified supplement entering Indonesia: BPOM + halal + commercial scaffolding 6-9 months, then 30-60 days for first clinic and pharmacy chain orders.
What kills timelines reliably: regulatory delays from ingredient documentation gaps (Certificate of Analysis missing or wrong format); payment terms misalignment (brand demanding LC, distributor refusing); shipping/customs surprises (the BPOM-Halal-BPJPH triple gate in Indonesia trips many brand operators); and brand impatience demanding launch before the chain is ready.